Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/150749
Share/Export:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Title

Benznidazole, the trypanocidal drug used for Chagas disease, induces hepatic NRF2 activation and attenuates the inflammatory response in a murine model of sepsis

AuthorsLambertucci, Flavia; Motiño, Omar CSIC ORCID CVN; Martín-Sanz, Paloma CSIC ORCID ; Carnovale, Cristina E.; Francés, Daniel E.; Ronco, María Teresa
KeywordsNRF2
Sepsis
CLP
Liver
Benznidazole
Issue Date2017
PublisherElsevier
CitationToxicology and Applied Pharmacology 315: 12-22 (2017)
AbstractMolecular mechanisms on sepsis progression are linked to the imbalance between reactive oxygen species (ROS) production and cellular antioxidant capacity. Previous studies demonstrated that benznidazole (BZL), known for its antiparasitic action on Trypanosoma cruzi, has immunomodulatory effects, increasing survival in C57BL/6 mice in a model of polymicrobial sepsis induced by cecal ligation and puncture (CLP). The mechanism by which BZL inhibits inflammatory response in sepsis is poorly understood. Also, our group recently reported that BZL is able to activate the nuclear factor erytroide-derived 2-Like 2 (NRF2) in vitro. The aim of the present work was to delineate the beneficial role of BZL during sepsis, analyzing its effects on the cellular redox status and the possible link to the innate immunity receptor TLR4. Specifically, we analyzed the effect of BZL on Nrf2 regulation and TLR4 expression in liver of mice 24 hours post-CLP. BZL was able to induce NRF2 nuclear protein localization in CLP mice. Also, we found that protein kinase C (PKC) is involved in the NRF2 nuclear accumulation and induction of its target genes. In addition, BZL prompted a reduction in hepatic CLP-induced TLR4 protein membrane localization, evidencing its immunomodulatory effects. Together, our results demonstrate that BZL induces hepatic NRF2 activation with the concomitant increase in the antioxidant defenses, and the attenuation of inflammatory response, in part, by inhibiting TLR4 expression in a murine model of sepsis.
URIhttp://hdl.handle.net/10261/150749
DOI10.1016/j.taap.2016.11.015
Identifiersdoi: 10.1016/j.taap.2016.11.015
e-issn: 1096-0333
issn: 0041-008X
Appears in Collections:(IIBM) Artículos




Files in This Item:
File Description SizeFormat
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work

CORE Recommender

SCOPUSTM   
Citations

17
checked on Jul 13, 2024

WEB OF SCIENCETM
Citations

14
checked on Feb 28, 2024

Page view(s)

338
checked on Jul 20, 2024

Download(s)

116
checked on Jul 20, 2024

Google ScholarTM

Check

Altmetric

Altmetric


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.